The Effect of Chamomile tea on anxiety and depression in cancer patients treated with chemotherapy

The Effect of Chamomile on anxiety and depression in cancer patients treated with chemotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017101422218N3

Enrollment

110

Registered

2017-11-08

Start date

2017-10-12

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer patients. Malignant neoplasm, unspecified

Interventions

Intervention 1: The intervention group will receive once in day for two weeks chamomile tea. Intervention 2: There is no intervention in the control group for patients.

Treatment - Drugs

The intervention group will receive once in day for two weeks chamomile tea

There is no intervention in the control group for patients.

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclussion Criteria: Diagnosis of cancer and chemotherapy ; Age between 18 to 65; Willingness to participate voluntarily in the study; The absence of mood disorder such as depression and anxiety previously known; Do not treat with psychosocial drugs; The condition of the patient be stable and the Oncology physician enters the patient into the study. Exclusion criteria: having reaction to Chamomile consumption; No tendency to continue the study; Patient death

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Depression and anxiety. Timepoint: two weeks. Method of measurement: beck questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactVahid Moeini Ghamchini

Neyshabur University of Medical Sciences

v.moini@yahoo.com+98 51 4225 4170

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026